<pages><page bbox="0.000,0.000,720.000,540.000" id="8" mean_title="[103.76764285714285, 442.9984642857143, 624.8131785714286, 489.46675]" rotate="0">
<title archetypal_index="0" bbox="62.592,450.078,657.317,490.038" id="0" size="39.96" Annotation_index="0">Tipranavir/r: Patient Population <textline bbox="62.592,450.078,657.317,490.038" colourspace="Pattern" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="39.960">Tipranavir/r: Patient Population </textline>
</title>
<enlisting archetypal_index="1" bbox="127.220,90.984,615.428,178.370" id="5" size="24.008" Annotation_index="1">&#8226; 97% of isolates resistant to at least 1 PI 
&#8226; 95% of isolates resistant to at least 1 NRTI 
&#8226; 75% of isolates resistant to at least 1 NNRTI <textline bbox="127.220,154.370,565.412,178.370" colourspace="Pattern" font="ArialMT" ncolour="1" size="24.000">&#8226; 97% of isolates resistant to at least 1 PI </textline>
<textline bbox="127.220,122.685,598.217,146.709" colourspace="Pattern" font="ArialMT" ncolour="1" size="24.024">&#8226; 95% of isolates resistant to at least 1 NRTI </textline>
<textline bbox="127.220,90.984,615.428,114.984" colourspace="Pattern" font="ArialMT" ncolour="1" size="24.000">&#8226; 75% of isolates resistant to at least 1 NNRTI </textline>
</enlisting>
<slide_number bbox="669.000,28.036,676.806,42.076" id="6" size="14.04" Annotation_index="2">8 <textline bbox="669.000,28.036,676.806,42.076" colourspace="Pattern" font="ArialMT" ncolour="0" size="14.040">8 </textline>
</slide_number>
<enlisting archetypal_index="2" bbox="55.2,186.178,612.475,396.471" Annotation_index="3">&#8226; Highly treatment experienced &#8211; 3 class experienced 
&#8211; Median number of 12 prior antiretroviral  &#8211; Prior T-20 use in 12% 
&#8211; Baseline resistance  <normal_text bbox="55.200,364.407,498.190,396.471" id="1" size="32.064">&#8226; Highly treatment experienced <textline bbox="55.200,364.407,498.190,396.471" colourspace="Pattern" font="ArialMT" ncolour="1" size="32.064">&#8226; Highly treatment experienced </textline>
</normal_text>
<normal_text bbox="91.224,290.358,612.475,355.278" id="2" size="27.96">&#8211; 3 class experienced 
&#8211; Median number of 12 prior antiretroviral  <textline bbox="91.224,327.318,361.394,355.278" colourspace="Pattern" font="ArialMT" ncolour="1" size="27.960">&#8211; 3 class experienced </textline>
<textline bbox="91.224,290.358,612.475,318.318" colourspace="Pattern" font="ArialMT" ncolour="1" size="27.960">&#8211; Median number of 12 prior antiretroviral  </textline>
</normal_text>
<normal_text bbox="91.224,186.178,382.788,251.098" id="4" size="27.96">&#8211; Prior T-20 use in 12% 
&#8211; Baseline resistance  <textline bbox="91.224,223.138,382.788,251.098" colourspace="Pattern" font="ArialMT" ncolour="1" size="27.960">&#8211; Prior T-20 use in 12% </textline>
<textline bbox="91.224,186.178,364.581,214.138" colourspace="Pattern" font="ArialMT" ncolour="1" size="27.960">&#8211; Baseline resistance  </textline>
</normal_text>
<normal_text bbox="113.780,260.113,191.752,288.097" id="3" size="27.984">drugs  <textline bbox="113.780,260.113,191.752,288.097" colourspace="Pattern" font="ArialMT" ncolour="1" size="27.984">drugs  </textline>
</normal_text>
</enlisting></page>
</pages>